Biotech Values

[jbog]

biomaven,

If teva eventually becomes another generic coupled with M-enox there's no where that type of profits that you expect.


The other day I laid out the scenario that Momenta's typical 10% sales royalty IS equivalent to 45%/50% of Sandoz's profit.